¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Studies in medieval culture."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® stool culture ÇÑ±Û ´ëº¯ ¹è¾ç
¼³¸í   
  ´ëº¯À» ´ëº¯Åë¿¡ Àû´ç·® ´ã¾Æ º¸³»°í, Á÷Àåµµ¸»(rectal swab: Á÷Á¢ Ç×¹®¿¡¼­ ´ëº¯À» ¹¯Çô¼­ ¹Þ¾Æ³»´Â °Í)°Ëü´Â µÎ°³ÀÇ ¸éºÀÀ» ¿î¹Ý¹èÁö¿¡ ³Ö¾î º¸³½´Ù. ¸ÕÀú ±×¶÷¿°»öÇÏ¿© ¹éÇ÷±¸°¡ º¸À̴ Áö¸¦ °üÂûÇÏ°í ¹éÇ÷±¸°¡ ¸¹ÀÌ º¸À̸頴ëºÎºÐ ¼¼±Õ¼º ÀÌÁúÀÏ °¡´É¼ºÀÌ ³ô´Ù. ¹è¾ç¹æ¹ýÀº ±Õ¿¡ µû¶ó ´Ù¸£¸ç »ì¸ð³Ú¶ó(Salmonella)´Â S-S ¿ì¹«¿¡ ¹è¾çÇϸ砿»½Ã´Ï¾Æ(Yersinia)´Â CIN ¿ì¹«¿¡ ¹è¾çÇϸç, ºñºê¸®¿À(Vibrio)´Â TCBS ¿ì¹«¿¡ ¹è¾çÇϸç, Å¬·Î½ºÆ®¸®µã(Clostridium)Àº TCCF ¿ì¹«¿¡ ¹è¾çÇϸç, ÃÖ±Ù ¹ß°ßµÈ Àå¿ëÇ÷¼º ´ëÀå±Õ(EHEC)Àº sorbital MAC ¿ì¹«¿¡¼­ ¹è¾çÇÑ´Ù.
¿µ¹® culture ÇÑ±Û ¹è¾ç
¼³¸í   
  ¹Ì»ý¹°À» ÀΰøÀû È¯°æÀ» Á¦°øÇÏ¿© ÀÚ¶ó°Ô Çϴ °ÍÀÌ´Ù. ¹è¾çƯ¡Àº »ê¼Ò°¡ ÀÖÀ¸¸é ´õ¿í Àß ÀÚ¶ó¸ç ¹è¾ç½Ã ÁÙ¸ð¾çÀ» Çü¼ºÇÔ. 10%ÀÇ ÀÌ»êȭź¼Ò¿¡ ÀÇÇØ ¼ºÀåÀÌ ÃËÁøµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • artificial culture medium
    Àΰø¹èÁö
  • aerobic culture
    À¯»ê¼Ò¹è¾ç
  • agar culture
    ¿ì¹«¹è¾ç
  • agar culture medium
    ¿ì¹«¹èÁö
  • anaerobic culture
    ¹«»ê¼Ò¹è¾ç
  • batch culture
    ÇѼܹè¾ç
  • bouillon culture
    °í±âÁó¹è¾ç
  • culture
    1. ¹è¾ç, ½É±â 2. ¹®È­
  • culture dish
    ¹è¾çÁ¢½Ã
  • culture fluid
    ¹è¾ç¾×
  • culture media
    ¹èÁö
  • culture medium
    1. ¹èÁö 2. ¹è¾ç±â
  • culture shock
    ¹®È­Ãæ°Ý
  • culture solution
    ¹è¾ç¾×
  • culture supernatant
    ¹è¾çÀ­¹°, ¹è¾ç»óû¾×
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • culture
    1.¹è¾ç, ½É±â, 2.¹®È­
  • mixed lymphocyte culture
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç
  • organ culture
    Àå±â¹è¾ç
  • quantitative culture
    Á¤·®¹è¾ç
  • tube culture
    ½ÃÇè°ü¹è¾ç
  • artificial culture medium
    Àΰø¹èÁö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aerobic culture
    »ê¼Ò¹è¾ç
  • agar culture
    ¿ì¹«¹è¾ç
  • anaerobic culture
    ¹«»ê¼Ò¹è¾ç
  • anaerobic culture system
    ¹«»ê¼Ò¹è¾ç±â
  • artificial culture medium
    Àΰø¹èÁö
  • axenic culture
    ¼ø¼ö¹è¾ç
  • batch culture
    ÇѼܹè¾ç
  • bouillon culture
    °í±âÁó¹è¾ç
  • culture
    ¹è¾ç, ½É±â
  • cell culture
    ¼¼Æ÷¹è¾ç
  • culture dish
    ¹è¾çÁ¢½Ã
  • culture fluid
    ¹è¾ç¾×
  • culture media
    ¹èÁö
  • culture medium
    ¹èÁö, ¹è¾ç±â
  • culture shock
    ¹®È­Ãæ°Ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • real-time studies
    ½Ç½Ã°£ °Ë»ç (ãùãÁÊà ËþÞÛ)
  • Maitlands culture method
    ¸¶ÀÌÆ®·£µå¹è¾ç¹ý
  • aerobic culture
    È£±â¼º ¹è¾ç(¡­ÛÆå×).
  • agar culture
    ÇÑõ¹è¾ç(ùÎô¸ÛÆå×).
  • artificial culture medium
    Àΰø¹èÁö(ìÑÍïÛÆò¢).
  • hanging drop culture
    ÇöÀû¹è¾ç(¡­ÛÆå×).
  • plate culture
    ÆòÆÇ¹è¾ç(øÁ÷ùÛÆå×).
  • pour culture
    ºÎ¾î½É±â(ÆòÆÇ)¹è¾ç
  • primary culture
    ÃÊ(´ë)¹è¾ç, ÀÏÂ÷¹è¾ç.
  • pure culture
    ¼ø(¼ö)¹è¾ç.
  • quantitative culture
    Á¤·®¹è¾ç(ïÒåÖÛÆå×).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • real-time studies
    ½Ç½Ã°£ °Ë»ç (ãùãÁÊà ËþÞÛ)
  • culture bottle =culture flask
    ¹è¾çº´ (¡­Üº).
  • aerobic culture
    È£±â¼º ¹è¾ç(¡­ÛÆå×).
  • agar culture
    ÇÑõ¹è¾ç(ùÎô¸ÛÆå×).
  • anaerobic culture
    Çø±â¹è¾ç(úîÑ¨ÛÆå×).
  • anaerobic culture
    Çø±â¹è¾ç(úîÑ¨ÛÆå×).
  • anaerobic culture system
    ¹«»ê¼Ò¹è¾çÀåÄ¡, ¹«»ê¼Ò¹è¾ç±â, ¹«»ê¼ÒÀåÄ¡
  • artificial culture medium
    Àΰø¹èÁö(ìÑÍïÛÆò¢).
  • bacterial culture
    ¼¼±Õ¹è¾ç(¡­ÛÆå×).
  • bacterial culture
    ¼¼±Õ¹è¾ç(ÛÆå×)
  • bacterial culture system
    ¼¼±Õ¹è¾ç±â, ¼¼±Õ¹è¾çÀåÄ¡
  • batch culture
    ¹îÃë¹è¾ç, ÇѼܹè¾ç, ÇÑÅÁ¹è¾ç
  • biphasic fungal blood culture bottl
    ÀÌ»ó¼º Áø±ÕÇ÷¾×¹è¾çº´(ܺ)
  • blood culture
    Ç÷¾×¹è¾ç
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • filter paper slant culture
    ¿©°úÁö»ç¸é¹è¾ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • batch culture
    ¹èÃë ¹è¾ç(ÛÆå×)
  • closed culture
    "¹ÐÆó¹è¾ç(ÚËøÍÛÆå×), batch culture"
  • continuous culture
    Áö¼Ó¹è¾ç(ò¥áÙÛÆå×)
  • culture
    ¹è¾ç(ÛÆå×)
  • enrichment culture
    º¸°­ ¹è¾ç (ÜÍË­ÛÆå×)
  • median tissue culture dose
    Á¤ÁßÁ¶Á÷¹è¾ç·®(ïáñéðÚòÄÛÆå×Õá)
  • mixed lymphocyte culture
    È¥ÇÕ(ûèùê)¸²ÆÄ±¸¹è¾ç(ÛÆå×)
  • open culture
    ¿­¸° ¹è¾ç(ÛÆå×)
  • primary culture
    ÀÏÂ÷ ¹è¾ç(ìéó­ÛÆå×)
  • primary tissue culture
    ÀÏÂ÷ Á¶Á÷¹è¾ç(ìéó­ðÚòÄÛÆå×)
  • pure culture
    ¼ø¼ö ¹è¾ç(âíâ¶ÛÆå×)
  • secondary culture
    ÀÌÂ÷ ¹è¾ç(ì£ó­ÛÆå×)
  • slant culture
    »ç¸é¹è¾ç(ÞØØüÛÆå×)
  • stab culture
    õÀÚ ¹è¾ç(ô¾í©ÛÆå×)
  • suspension culture
    Çöʹè¾ç (úØöúÛÆå×)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sputum culture
    ´ã¹è¾ç
  • tissue culture
    Á¶Á÷¹è¾ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MLC minimum lethal concentration; mixed leukocyte culture; mixed ligand chelate; mixed lymphocyte concen...
TC target cell; taurocholate; temperature compensation; teratocarcinoma; tertiary cleavage; tetracyclin...
TCID tissue culture infective dose; tissue culture inoculated dose
TCID50 median tissue culture infective dose; 50% tissue culture infective dose
CAS calcarine sulcus; calcific aortic stenosis; Cancer Attitude Survey; carbohydrate-active steroid; car...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CES-D Center for Epidemiologic Studies - Depression
CES-D Center for Epidemiologic Studies - Depression Scale
CES-D Center for Epidemiological Studies Depression
CESD Centers for Epidemiological Studies Depression Scale
EPS Electrophysiologic Studies
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 25201
    JournalTitle: Studies in medieval culture.
    MedAbbr: Stud Mediev Cult
    ISSN: 0085-6878
    ESSN:
    IsoAbbr:
    NlmId: 100970706
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • agar culture
    ÇÑõ ¹è¾ç
  • blood culture
    Ç÷¾× ¹è¾ç
  • cell culture biocompatibility test
    ¼¼Æ÷ ¹è¾ç »ýü ÀûÇÕ¼º °Ë»ç¹ý
  • culture
    ¹è¾ç
    ¹Ì»ý¹°À» ÀΰøÀûÀ¸·Î Áõ½Ä½ÃŰ´Â Á¶ÀÛ. ¹è¾ç¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÀÎÀÚ·Î »ê¼Ò, ¹èÁöÀÇ
  • culture medium
    ¹èÁö, ¹è¾ç±â
    »ýÁ¸Çϰí ÀÖ´Â ¼¼Æ÷ÀÇ ¹è¾ç¿¡ »ç¿ëµÇ´Â ¹°Áú ¶Ç´Â Á¶Á¦¹°.
  • culture requirement
    ¹è¾ç ¿ä±¸
  • egg culture
    ³­ ¹è¾ç
  • Jacobsen's culture medium
    ¾ßÄß¼¾ ¹è¾ç±â
    Á¦ÀÌÀλê Ä®·ý, ¿°È­¾Ï¸ó, ¿°È­ ¸¶±×³×½·, ź»ê¼®È¸·Î ÀÌ·ç¾îÁø´Ù.
  • mixed lymphocyte culture
    È¥ÇÕ ¸²ÇÁ±¸ ¹è¾ç
  • needle culture
    õÀÚ ¹è¾ç
  • plate culture
    ÆòÆÇ ¹è¾ç
  • primary culture
    Ãʹè¾ç, ÃÊ´ë ¹è¾ç, ÀÏÂ÷ ¹è¾ç
  • pure culture
    ¼ø¹è¾ç, ¼ø¼ö ¹è¾ç
  • rollertube culture
    ½ÃÇè°ü ȸÀü ¹è¾ç
  • sputum culture
    ´ã¹è¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
history of medicine, medieval The period of the history of medicine from 500 through 1450 a.d.
(12 Dec 1998)
retrospective studies Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
(12 Dec 1998)
pharmalogical studies <pharmacology> Studies to assess the potential harmful or other effects of drugs
(16 Dec 1997)
clinical studies <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product.
(14 Nov 1997)
cohort studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
(12 Dec 1998)
combination studies <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs.
(09 Jan 1998)
multicenter studies Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.
(12 Dec 1998)
multivariate studies The use of statistical techniques for the simultaneous investigations of the influence of several variables.
(05 Mar 2000)
preclinical studies <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application.
(14 Nov 1997)
sampling studies Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled.
(12 Dec 1998)
prospective studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
(12 Dec 1998)
his bundle studies <cardiology> This test studies the electrical activity of the bundle of HIS.
The bundle of HIS is a group of electrical fibres in the heart that are responsible for transmitting the electrical impulses which generate a normal cardiac contraction. This test may be performed in cases of cardiac arrhythmias, to locate a specific area responsible for a conduction defect and to determine the need for cardiac pacemaker placement.
The test involves the passage of a an electrode tipped catheter into the heart. This catheter is usually threaded through a neck, arm or chest vein. Measurements of the HIS bundle can then be performed while standard ECG leads are placed on the arms and legs.
This test carries a small risk of bleeding, arrhythmias, embolism, heart attack and stroke. It is performed by a specially trained cardiologist.
(27 Sep 1997)
immunofluorescent studies <technique> A special assay that relies on the production of measurable fluorescent light. An immunofluorescent tagged antibody interacts and binds with an antigen allowing an indirect measurement of its concentration.
(27 Sep 1997)
intervention studies Epidemiologic investigations designed to test a hypothesised cause-effect relation by modifying the supposed causal factor(s) in the study population.
(12 Dec 1998)
intracardiac electrophysiology studies <cardiology, investigation> A special study that involves the placement of electrodes inside the heart to map the electrical characteristics of the heart.
This study is carried out in a specially equipped lab and is similar to a cardiac catheterisation procedure. Electrodes are placed inside the heart via a catheter placed into a vein. The electrodes are positioned near the heart's conduction system and an electrical map of the heart can be determined.
This test is often performed in those where a life-threatening cardiac arrhythmia is a problem. The location and characteristics of an arrhythmia can be determined, thus guiding medical management of the problem. Patients with Wolf Parkinson White syndrome or sick sinus syndrome may have this test as part of their evaluation.
(27 Sep 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • International Institute for Strategic Studies
    (¿µ)±¹Á¦ Àü·«¿¬±¸¼Ò(I.I.S.S)
  • peace studies
    ÆòÈ­ ¿¬±¸(°­ÁÂ)
  • Medieval Latin
    Áß¼¼ ¶óƾ¾î(º¸Åë A D 700-1500 ³âÀÇ °Í)
  • medieval
    Áß¼¼(dz)ÀÇ
  • medieval history
    Áß¼¼»ç(¼­·Î¸¶ Á¦±¹ÀÇ ¸ê¸Á(476³â)¿¡¼­ ¸£³×»ó½º±îÁö)
  • culture
    ¹®È­,°æÀÛ,±³¾ç
  • bee culture
    ¾çºÀ
  • culture
    ±³¾ç;¼¼·Ã;¹®È­;Á¤½Å ¹®¸í;°³È­;ÈÆ·Ã;¼ö¾ç;¾ç½Ä;Àç¹è;¹è¾ç;¹è¾ç±Õ;(¼¼±ÕÀ»)¹è¾çÇÏ´Ù;Àç¹èÇÏ´Ù;°æÀÛÇÏ´Ù;±³È­ÇÏ´Ù
  • culture area
    (°øÅëÀÇ)¹®È­ ¿µ¿ª
  • culture complex
    ¹®È­ º¹ÇÕü
  • culture feature
    (ÇÑ Áö¿ªÀÇ)ÀΰøÀû Ư¡(µµ·Î,±³·®.Áý µî)
  • culture gap
    ¹®È­°£ÀÇ °ÝÂ÷
  • culture hero
    ¹®È­ ¿µ¿õ(¹®È­¸¦ â½ÃÇÑ,¶Ç´Â »çȸÀÇ ÀÌ»óÀ» ±¸ÇöÇÑ ½ÅÈ­Àû.Àü¼³Àû Àι°)
  • culture lag
    =CULTURAL LAG
  • culture medium
    ¹èÁö;¹è¾ç±â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á